FDA Investigator Carlyn L Ray
Carlyn L Ray has inspections in 1 countries as of 10 Nov 2022. Carlyn L Ray has collaborated with a combined 1279 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
10 Nov 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amanda Dinaro,
Amanda S Zorn,
Ana L Kewes,
Anthony R Ronga,
Ashley L Reiber,
Brian D Nicholson,
Brian P Emanuel,
Brittani N Franklin,
Bruce H Mccullough,
Carrie Ann Plucinski,
Chad E Schmear,
Charlie P Booker,
Cheryl A Kmiec,
Christina A Miller,
Christopher B Harding,
Christopher D Leach,
Clotia Cabbey Mensah,
Daniel B Arrecis,
Dariusz Galezowski,
Darrell E Luedtke,
David Perkins,
Debra I Love,
Eric S Pittman,
Freed A Sharif,
Humera T Khan,
James T Karpus,
James W Plucinski,
Jason F Chancey,
Jesse A Vazquez,
Jessica L Burley,
Jocelyn C Turner,
John M Seale,
Joseph D Cooper,
Joshua M Adams,
Karen Emasley Joseph,
Kathleen S Tormey,
Kristen E Szenderski,
Kujtim Sadiku,
Lana K Waselewski,
Larry F Hallberg,
Latoya A Griffith,
Lauren A Crivellone,
Leeterry Moore,
Lequita M Mayhew,
Leslie D Hintz,
Lisa C Lewis,
Lisa Hayka,
Logan M Ebeling,
Maria Diaz,
Mark I Kaspar,
Matthew J Sienko,
Natasha R Johnson,
Nicholas F Lyons,
Nicholas Z Lu,
Nicole J Clausen,
Nicole S Williams,
Pablo Alcantara,
Paola S Barnett,
Patricia A Mcilroy,
Rachel T Evans,
Rosemary A Sexton,
Russell K Riley,
State Agency,
Stephanie A Wright,
Stephen D Eich,
Sullan,
Susan M Jackson,
Susan P Bruederle,
Susan W Ciani,
Tarsha T Mcclendon,
That Q Dang,
Todd M Stankewicz,
Todd Q Dang,
William R Weissinger
Carlyn L Ray's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2002 | EIR | AndersonBrecon, Inc. d.b.a. PCI of Illinois - EIR, 2002-08-05 |
August, 2002 | EIR | ANDERSONBRECON INC. - EIR, 2002-08-02 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more